1. Home
  2. BCYC vs EMD Comparison

BCYC vs EMD Comparison

Compare BCYC & EMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • EMD
  • Stock Information
  • Founded
  • BCYC 2009
  • EMD 2003
  • Country
  • BCYC United Kingdom
  • EMD United States
  • Employees
  • BCYC N/A
  • EMD N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • EMD Finance/Investors Services
  • Sector
  • BCYC Health Care
  • EMD Finance
  • Exchange
  • BCYC Nasdaq
  • EMD Nasdaq
  • Market Cap
  • BCYC 620.7M
  • EMD 587.9M
  • IPO Year
  • BCYC 2019
  • EMD N/A
  • Fundamental
  • Price
  • BCYC $8.56
  • EMD $9.86
  • Analyst Decision
  • BCYC Buy
  • EMD
  • Analyst Count
  • BCYC 8
  • EMD 0
  • Target Price
  • BCYC $29.14
  • EMD N/A
  • AVG Volume (30 Days)
  • BCYC 331.4K
  • EMD 248.5K
  • Earning Date
  • BCYC 05-01-2025
  • EMD 01-01-0001
  • Dividend Yield
  • BCYC N/A
  • EMD 10.25%
  • EPS Growth
  • BCYC N/A
  • EMD N/A
  • EPS
  • BCYC N/A
  • EMD N/A
  • Revenue
  • BCYC $35,275,000.00
  • EMD N/A
  • Revenue This Year
  • BCYC N/A
  • EMD N/A
  • Revenue Next Year
  • BCYC $18.29
  • EMD N/A
  • P/E Ratio
  • BCYC N/A
  • EMD N/A
  • Revenue Growth
  • BCYC 30.76
  • EMD N/A
  • 52 Week Low
  • BCYC $8.20
  • EMD $7.85
  • 52 Week High
  • BCYC $28.67
  • EMD $9.55
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 29.39
  • EMD 51.62
  • Support Level
  • BCYC $8.60
  • EMD $9.76
  • Resistance Level
  • BCYC $9.69
  • EMD $9.92
  • Average True Range (ATR)
  • BCYC 0.67
  • EMD 0.09
  • MACD
  • BCYC 0.00
  • EMD 0.00
  • Stochastic Oscillator
  • BCYC 6.05
  • EMD 73.08

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

About EMD Western Asset Emerging Markets Debt Fund Inc

Western Asset Emg Markets Debt Fund Inc is a non-diversified closed-end management investment company. Its primary investment objective is to seek high current income and the secondary objective is to seek capital appreciation.

Share on Social Networks: